tiprankstipranks
Silo Pharma (SILO)
NASDAQ:SILO
US Market

Silo Pharma (SILO) Technical Analysis

38 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Silo Pharma’s (SILO) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Silo Pharma is a Sell.
Silo Pharma’s (SILO) 20-Day exponential moving average is 1.94, while Silo Pharma’s (SILO) share price is $2, making it a Sell.
Silo Pharma’s (SILO) 50-Day exponential moving average is 1.87, while Silo Pharma’s (SILO) share price is $2, making it a Buy.

Silo Pharma (SILO) Pivot Points

May 31, 2024, 09:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.63
1.73
1.84
1.94
2.05
2.15
2.26
Fibonacci
1.73
1.81
1.86
1.94
2.02
2.07
2.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silo Pharma (SILO) Moving Averages

May 31, 2024, 09:30 AM
Period
Simple
Exponential
MA5
2.02Sell
1.97Sell
MA10
2.00Sell
1.97Sell
MA20
1.89Buy
1.94Sell
MA50
1.91Buy
1.87Buy
MA100
1.73Buy
1.80Buy
MA200
1.69Buy
1.81Buy
Silo Pharma’s (SILO) 10-Day exponential moving average is 1.97, while Silo Pharma’s (SILO) share price is $2, making it a Sell.
Silo Pharma’s (SILO) 100-Day exponential moving average is 1.80, while Silo Pharma’s (SILO) share price is $2, making it a Buy.
Silo Pharma’s (SILO) stock price is $2 and Silo Pharma’s (SILO) 50-day simple moving average is 1.91, creating a Buy signal.
Silo Pharma’s (SILO) stock price is $2 and Silo Pharma’s (SILO) 100-day simple moving average is 1.73, creating a Buy signal.
Silo Pharma’s (SILO) stock price is $2 and Silo Pharma’s (SILO) 200-day simple moving average is 1.69, creating a Buy signal.

Silo Pharma (SILO) Technical Indicators

May 31, 2024, 09:30 AM
Name
Value
Implied Action
RSI (14)
50.01
Neutral
STOCH (9,6)
29.74
Neutral
STOCHRSI (14)
37.62
Neutral
MACD (12,26)
0.04
Sell
ADX (14)
21.42
Neutral
Williams %R
-64.29
Buy
CCI (14)
36.46
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
49.13
Neutral
ROC
6.67
Buy
Silo Pharma’s (SILO) Relative Strength Index (RSI) is 50.01, creating a Neutral signal.
Silo Pharma’s (SILO) Trend Strength Indicator (ADX) is 21.42, creating a Neutral signal.
Silo Pharma’s (SILO) Commodity Channel Index (CCI) is 36.46, creating a Neutral signal.
Silo Pharma’s (SILO) Price Rate of Change (ROC) is 6.67, creating a Buy signal.

FAQ

Is SILO a Buy, Hold, or Sell?
Based on SILO’s technical indicators, SILO is a Buy.
    What is SILO’s RSI (14)?
    SILO’s RSI (14) is 50.01, which suggests SILO is a Neutral.
      What is SILO’s MACD?
      SILO’s MACD is 0.04, which suggests SILO is a Sell.
        What is SILO’s 5-day moving average?
        SILO’s 5-day moving average is 2.02, which suggests SILO is a Sell.
          What is SILO’s 20-day moving average?
          SILO 20-day moving average is 1.89, which suggests SILO is a Buy.
            What is SILO’s 50-day moving average?
            SILO’s 50-day moving average is 1.91, which suggests SILO is a Buy.
              What is SILO’s 200-day moving average?
              SILO’s 200-day moving average is 1.69, which suggests SILO is a Buy.
                What is SILO’s Williams % R (14)?
                SILO’s Williams % R (14) is -64.29, which suggests SILO is a Buy.
                  What is SILO’s CCI (14)?
                  SILO’s CCI (14) is 36.46, which suggests SILO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis